1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Applications are by invitation only — no open application deadline listed.
Fund for Health Equity is sponsored by Direct Relief. Direct Relief's Fund for Health Equity provides financial support to community health centers, free and charitable clinics, educational institutions, and other grassroots organizations. The fund supports organizations working to close health gaps by diversifying the healthcare workforce, eliminating health disparities, and supporting technology and innovation.
It prioritizes organizations addressing critical social determinants of health such as education, employment, income, social support, community safety, and housing.
Get alerted about grants like this
Save a search for “Direct Relief” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Health Equity | Issues & Solutions | Direct Relief Direct Relief’s Fund for Health Equity expands access to healthcare and improves health outcomes for marginalized communities. Dr. Keith Winfrey, chief medical officer at NOELA Community Health Center, examines a patient. (Courtesy photo) Through the Fund for Health Equity, Direct Relief supports grassroots organizations tackling health inequities.
These organizations—deeply embedded in their communities—are diversifying the healthcare workforce, reducing health disparities, and leveraging technology to improve access to reliable care. Health outcomes are shaped by multiple factors, including education, employment, income, social support, community safety, air and water quality, housing, transportation, and personal behaviors.
The Fund prioritizes organizations addressing these critical determinants of health. Addressing Inequities in Health Marginalized communities have long experienced worse health outcomes and are less likely to receive the medical care they need. That’s true of people of color, LGBTQ+ individuals, people experiencing homelessness, and others as well.
These striking injustices are one of the modern-day effects of a long history of discriminatory practices, policies, and traditions. Access to health care is just a single aspect of a person’s health. Race and ethnicity, housing situation, employment status, living environment, and spoken language, among other interrelated factors, will all play significant roles in an individual’s health outcomes.
Aaron E.
Henry Health Center Alaska Native Heritage Center Centro Hispano De East Tennessee Cheyenne River Youth Project Healthy Mothers, Healthy Babies Northern Cheyenne Reservation Training the Next Generation University of Texas – Project Hope The Fund for Health Equity Direct Relief’s Fund for Health Equity provides financial support to community health centers, free and charitable clinics, educational institutions, and other grassroots organizations working to close health gaps.
The Fund is guided by an Advisory Council with deep expertise in communities affected by socioeconomic disparities.
Advisory Council Members: Co-Chair: Regina Benjamin, MD, MBA – 18th U.S. Surgeon General, Founder of BayouClinic, Inc. Co-Chair: Byron Scott, MD, MBA – Chief Health Officer, Direct Relief Martha Dawson, DNP, MSN, RN, FACHE – Associate Professor, University of Alabama at Birmingham; Former President, National Black Nurses Association Jane Delgado, Ph. D.
, MS – President & CEO, National Alliance for Hispanic Health Gail Small, JD – Head Chief Woman, Northern Cheyenne Tribe The Fund for Health Equity supports organizations making measurable progress in three key areas: 1.
Diversification of the Healthcare Workforce Direct Relief’s goal is to support people from all backgrounds as they undergo the certification and training to become nurses, community health workers, health navigators, and other essential health care workers and make these career paths more accessible to diverse groups of people. 2.
Elimination of Health Disparities A wide range of factors, from the living environment to financial situations, will play a role in a person’s health outcomes. Direct Relief funds organizations working to reduce these disparities while improving population health, preventing disease, and responding to behavioral health and substance abuse challenges. 3.
Support of Technology and/or Innovation Many organizations use new technology – including telehealth platforms, mobile medical units, and renewable energy – to expand access and deliver better patient care through innovative technology that enhances providers’ ability to support patients and respond to the needs of their respective communities.
Since 2021, Direct Relief has granted more than $59 million to 184 organizations across the U.S. through the Fund for Health Equity. Applications to the Fund are by invitation only. Fund for Health Equity Grantees Hover over a location for additional details You don’t have to donate.
That’s why it’s so extraordinary if you do. This form needs Javascript to display, which your browser doesn't
Based on current listing details, eligibility includes: Community health centers, free and charitable clinics, educational institutions, and other grassroots organizations working to close health gaps. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Not specified Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Past winners and funding trends for this program
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.